These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10865170)

  • 1. Modulation of lymphocyte proliferative responses by a canine Lyme disease vaccine of recombinant outer surface protein A (OspA).
    Chiao JW; Villalon P; Schwartz I; Wormser GP
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):193-6. PubMed ID: 10865170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
    Stover CK; Bansal GP; Hanson MS; Burlein JE; Palaszynski SR; Young JF; Koenig S; Young DB; Sadziene A; Barbour AG
    J Exp Med; 1993 Jul; 178(1):197-209. PubMed ID: 8315378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
    Edelman R; Palmer K; Russ KG; Secrest HP; Becker JA; Bodison SA; Perry JG; Sills AR; Barbour AG; Luke CJ; Hanson MS; Stover CK; Burlein JE; Bansal GP; Connor EM; Koenig S
    Vaccine; 1999 Feb; 17(7-8):904-14. PubMed ID: 10067697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
    Ma Y; Weis JJ
    Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination as a modality to prevent Lyme disease. A status report.
    Wormser GP
    Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
    Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT
    J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant vaccine for Lyme disease.
    Wallich R; Kramer MD; Simon MM
    Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
    Tai KF; Ma Y; Weis JJ
    Infect Immun; 1994 Feb; 62(2):520-8. PubMed ID: 8300210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes.
    Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R
    Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.
    Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM
    Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
    Wormser GP
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115572. PubMed ID: 34763193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity.
    Foley DM; Wang YP; Wu XY; Blanco DR; Lovett MA; Miller JN
    J Clin Invest; 1997 Apr; 99(8):2030-5. PubMed ID: 9109448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for a vaccine to prevent Lyme disease in humans.
    Wormser GP
    Clin Infect Dis; 1995 Nov; 21(5):1267-74. PubMed ID: 8589153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.